Global biopsy devices market projected to hit $4.02b by 2033

Thanks to advancements in medical technology.

The global biopsy devices market is projected to rise to $4.02b by 2033 at a compound annual growth rate of 5.75%, according to Research and Markets.

The sector’s expansion is attributed to developments in medical technology, the rising prevalence of cancer and other chronic diseases, and the growing demand for minimally invasive diagnostic procedures.

In addition, the adoption of automated and precision biopsy devices in healthcare is contributing to market growth.

Core needle biopsy, FNA, and vacuum-assisted biopsy devices are the sector's most commonly utilised technologies.

“Advancements in biopsy technology include image-guided biopsy devices that use ultrasound, CT scans, or MRI for greater precision,” the report said.